# Heidi Gillmore

> Heidi Gillmore is a commercial leadership executive at TerSera Therapeutics, the Deerfield, Illinois specialty pharmaceutical company she helped build from its 2016 inception. Across roles spanning marketing, strategy, business development and running TerSera's US oncology business, she has helped turn a portfolio of 'one-and-only' therapeutics, including the prostate and breast cancer drug Zoladex, into a durable commercial enterprise. A University of Northern Iowa graduate with a University of Chicago credential, she sits on the board of the Illinois Biotechnology Innovation Organization and has spent her career taking specialty and orphan medicines from acquisition to market.

- **Role:** Senior leadership executive (strategy, corporate marketing and business development) at TerSera Therapeutics
- **Organizations:** TerSera Therapeutics, Crealta Pharmaceuticals, Horizon Pharma, Takeda Pharmaceuticals North America, TAP Pharmaceuticals, Arthur Andersen, Illinois Biotechnology Innovation Organization (iBIO)
- **Nationality:** American
- **Education:** Bachelor of Arts, University of Northern Iowa, Graduate Certificate (Health Administration & Policy), University of Chicago
- **Known for:** Helped build TerSera Therapeutics from its 2016 founding into an established specialty pharmaceutical company, Held multiple commercial leadership roles at TerSera including running the US Oncology Business Unit, Led marketing at Crealta Pharmaceuticals through its acquisition by Horizon Pharma

## Career timeline

- **Early career** — Worked at Arthur Andersen in the supply chain technology services practice within the firm's business consulting division
- **2000s-2012** — Held marketing, market access and business development roles at TAP Pharmaceuticals and Takeda Pharmaceuticals North America
- **2012-2014** — Senior Director and Global Brand Lead for the Gout Franchise at Takeda Pharmaceuticals
- **2014-2016** — Vice President, Marketing at Crealta Pharmaceuticals (acquired by Horizon Pharma in January 2016)
- **2016** — Joined TerSera Therapeutics at its inception; held multiple commercial leadership roles
- **2016-present** — Progressed through SVP/GM roles including US Oncology Business Unit and Specialty Products & Commercial Excellence, and Senior VP, Strategy & Corporate Marketing
- **2024** — Elected to the Board of Directors of the Illinois Biotechnology Innovation Organization (iBIO)

## Achievements

- Helped build TerSera Therapeutics from its 2016 founding into an established specialty pharmaceutical company
- Held multiple commercial leadership roles at TerSera including running the US Oncology Business Unit
- Led marketing at Crealta Pharmaceuticals through its acquisition by Horizon Pharma
- Appointed to the Board of Directors of the Illinois Biotechnology Innovation Organization in 2024

## Latest updates

- **2024-01** — Elected to the Board of Directors of the Illinois Biotechnology Innovation Organization (iBIO).

## Links

- Website: https://tersera.com
- LinkedIn: http://www.linkedin.com/in/heidigillmore

---

Profile page: https://yespress.io/heidi-gillmore
Published by YesPress — https://yespress.io
Last updated: 2026-06-12